Clinical Factors Related to Cardiac Conduction Disturbance in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy Undergoing Tafamidis Treatment

Background: Cardiac conduction disturbances are frequently observed in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Because their relationships with other clinical factors have not been fully investigated, in this study we evaluated changes in atrioventricular conduction disturbances (AVCD) and intraventricular conduction disturbances (IVCD) in patients with ATTR-CM undergoing tafamidis treatment, with the aim of identifying clinical factors, including cardiac magnetic resonance (CMR) parameters, related to AVCD and IVCD.